Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Business Insights: Page 3
Thorne Healthtech, Arome Science partner to develop next-generation metabolomics test
Research studies using the test will leverage at-home blood collection conducted using its OneDraw medical device, Thorne HealthTech said.
May 15, 2023
Beckman Coulter Diagnostics announces global launch of immunoassay analyzer
The analyzer can run up to 215 tests per hour per square meter and, according to Beckman Coulter Diagnostics, beta users attest to a feature that redefines their workday with no daily maintenance requirements.
May 15, 2023
Detecting potentially treatable causes of cognitive decline
Dr. Michael K. Racke, medical director for neurology at Quest Diagnostics, spoke to LabPulse about the challenges associated with identifying those who do not have Alzheimer's and may have reversible conditions that mimic dementia.
May 15, 2023
OraSure Technologies Q1 revenues up 129% on COVID-19 rapid immunoassay sales
Demand for rapid tests is tapering, and OraSure is scaling-down COVID-19 test manufacturing amid staff layoffs.
May 11, 2023
BioMérieux receives FDA CLIA waiver for multiplex PCR respiratory panel
In about 15 minutes, the panel detects five of the most common viral causes of upper respiratory tract infections: SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus (RSV), and rhinovirus.
May 11, 2023
Capitainer secures $5.7M to advance self-sampling technology
Capitainer will use the funding to increase production capacity, develop new products, and intensify sales and marketing efforts.
May 11, 2023
FDA grants de novo request enabling the marketing of QuidelOrtho SARS-CoV-2 antibody tests
The tests are intended for prescription use only for the qualitative detection of IgG antibodies to SARS-CoV-2 to aid in identifying patients who have an adaptive immune response to SARS-CoV-2 from either a recent or prior infection.
May 10, 2023
Thermo Fisher Scientific, Pfizer collaborate to broaden NGS testing in underserved countries
Under the agreement, Thermo Fisher will select local labs for its NGS technology, ensuring they have the infrastructure, trained staff, and quality control measures to meet industry standards to conduct NGS testing for breast and lung cancer.
May 9, 2023
California man guilty in testing kickback scheme
According to information presented in court, the defendant conspired with others to pay and receive kickbacks in exchange for the referral of pharmacogenomic (PGx) tests.
May 10, 2023
Patients concerned about Medicare policy that limits coverage of noninvasive post-transplant tests
In a survey, 95% of patient participants said they believe that reduced coverage for noninvasive tests would negatively impact their post-transplant care.
May 12, 2023
Exact Sciences shares rise on 24% Q1 revenue growth, higher 2023 guidance
The firm is seeing a “dramatic increase in the electronic ordering rate” at health systems, which is helping grow sales, its CEO Kevin Conroy said.
May 10, 2023
Siemens Healthineers Q2 diagnostics revenues drop 39% on decline in rapid antigen test sales
The firm is seeing a return to low- to mid-single digital revenue growth as swings in demand from COVID-19 testing to routine testing normalize, Sharon Bracken, its president of diagnostics, said in an interview.
May 10, 2023
Previous Page
Page 3 of 156
Next Page